Payment overview · 2025
General Payments
$28.53
1 reported records · 1 companies
Healthcare provider profile · identity verified
Joseph E. Stella, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · SCRANTON, PA · NPI 1316995780
Verified facts
What the public records show
CMS Open Payments records show Joseph E. Stella, M.D. received $28.53 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 127 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $28.53 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $28.53 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $28.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
127 | 30 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 819 | 223 |
| Omeprazole | Omeprazole | 500 | 128 |
| Levothyroxine Sodium | Levothyroxine Sodium | 474 | 114 |
| Lisinopril | Lisinopril | 446 | 126 |
| Gabapentin | Gabapentin | 409 | 75 |
| Amlodipine Besylate | Amlodipine Besylate | 406 | 114 |
| Alprazolam | Alprazolam | 377 | 63 |
| Metoprolol Succinate | Metoprolol Succinate | 336 | 90 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 275 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 270 | 69 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 268 | 82 |
| Lorazepam | Lorazepam | 263 | 41 |
| Furosemide | Furosemide | 260 | 63 |
| Losartan Potassium | Losartan Potassium | 242 | 65 |
| Metformin Hcl | Metformin Hcl | 235 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 220 | 56 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 218 | 32 |
| Eliquis | Apixaban | 214 | 35 |
| Clonazepam | Clonazepam | 201 | 24 |
| Simvastatin | Simvastatin | 186 | 43 |
| Oxycodone Hcl | Oxycodone Hcl | 172 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 164 | 64 |
| Metformin Hcl Er | Metformin Hcl | 163 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 159 | 38 |
| Ibuprofen | Ibuprofen | 157 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 129 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 127 | 30 |
| Ozempic | Semaglutide | 127 | 30 |
| Atenolol | Atenolol | 125 | 34 |
| Jardiance | Empagliflozin | 117 | 30 |
| Sertraline Hcl | Sertraline Hcl | 110 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 34 |
| Prednisone | Prednisone | 108 | 67 |
| Diazepam | Diazepam | 106 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 105 | 27 |
| Montelukast Sodium | Montelukast Sodium | 102 | 22 |
| Trulicity | Dulaglutide | 101 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 100 | 28 |
| Potassium Chloride | Potassium Chloride | 98 | 29 |
| Warfarin Sodium | Warfarin Sodium | 98 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 95 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 92 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 90 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 25 |
| Trazodone Hcl | Trazodone Hcl | 88 | 23 |
| Allopurinol | Allopurinol | 83 | 18 |
| Pregabalin | Pregabalin | 79 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 75 | 20 |
| Buspirone Hcl | Buspirone Hcl | 74 | 15 |
| Famotidine | Famotidine | 74 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 73 | 20 |
| Spironolactone | Spironolactone | 71 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 70 | 23 |
| Clonidine Hcl | Clonidine Hcl | 69 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 12 |
| Amoxicillin | Amoxicillin | 66 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 18 |
| Nystatin | Nystatin | 65 | 15 |
| Carvedilol | Carvedilol | 64 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | suppressed |
| Methocarbamol | Methocarbamol | 63 | 12 |
| Tramadol Hcl | Tramadol Hcl | 63 | 19 |
| Glipizide Er | Glipizide | 60 | 20 |
| Torsemide | Torsemide | 60 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 59 | 12 |
| Ezetimibe | Ezetimibe | 57 | 18 |
| Ventolin Hfa | Albuterol Sulfate | 56 | 15 |
| Sucralfate | Sucralfate | 54 | 12 |
| Glimepiride | Glimepiride | 52 | 15 |
| Baclofen | Baclofen | 50 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 50 | 22 |
| Finasteride | Finasteride | 50 | 12 |
| Meloxicam | Meloxicam | 49 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 46 | suppressed |
| Ondansetron Odt | Ondansetron | 45 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | 13 |
| Loperamide | Loperamide Hcl | 44 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 44 | 17 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 41 | suppressed |
| Synthroid | Levothyroxine Sodium | 41 | suppressed |
| Tradjenta | Linagliptin | 41 | 11 |
| Alendronate Sodium | Alendronate Sodium | 40 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 40 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 27 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | suppressed |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 34 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 31 | 11 |
| Mounjaro | Tirzepatide | 30 | suppressed |
| Nitroglycerin | Nitroglycerin | 30 | 14 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 30 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Azithromycin | Azithromycin | 25 | 23 |
| Mupirocin | Mupirocin | 25 | 12 |
| Temazepam | Temazepam | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 23 |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 12 |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 15 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 17 |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 14 |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | 11 |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Lacosamide | Lacosamide | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 16 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Misoprostol | Misoprostol | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | 12 |
| Felodipine Er | Felodipine | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Cetirizine Hcl | Cetirizine Hcl | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Efavirenz-Emtric-Tenofov Disop | Efavirenz/Emtricit/Tenofovr Df | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $28.53 · 1 records | Novo Nordisk Inc | Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error